In MTS group, we found GABA antibodies in 4 (23.5%) patients, NMDA-R antibodies in 1 (5.9%), recoverin antibody in 1 (5.9%), GAD, Tr, and CV2 antibodies in 1 (5.9%), and finally dsDNA in 1 (5.9%), patient. The gene discussed is GAD1; the disease is deafness dystonia syndrome.